Finegan Michael 4

What Happened
Michael Finegan, a director of Orthofix Medical Inc. (OFIX), was granted 20,721 deferred stock units on 2026-06-10. The grant was recorded on the Form 4 as an acquisition at $0.00 (an award rather than a purchase), so no cash changed hands. Those units are a contingent right to receive one share each once vested.

Key Details

• Transaction date: 2026-06-10; Filing date: 2026-06-12 (filed within the typical two-business-day window).
• Transaction type/code: A (Award/Grant). Price reported: $0.00 per unit.
• Grant size: 20,721 deferred stock units.
• Implied holdings per filing: the filing references 55,805 previously reported deferred stock units plus 3,505 shares from the company’s Stock Purchase Plan (SPP); combined with the new 20,721 grant, the filing implies beneficial ownership of 80,031 shares/units (59,310 prior + 20,721 new).
• Footnote F1: These are deferred stock units that vest in full on the first anniversary of the grant date (subject to continued service). Each unit converts to one share; vested units will settle into common stock within 45 days after the reporting person’s termination of service.
• Footnote F2: Notes the 55,805 previously reported deferred units and 3,505 SPP shares. SPP purchases are exempt from Section 16(b) under Rule 16b-3(b)(5).

Context
This is an equity award (deferred stock units), not an open-market purchase or sale. Deferred grants are common as part of director compensation and should not be interpreted as an immediate buy/sell signal. The award vests after one year and converts to shares only upon vesting (or within 45 days of termination under the plan).